Fund Holdings — Vestal Point Capital, LP

Total Portfolio Value:
$1.34B
Total Bought:
$552.29M
Total Sold:
$400.55M
Net Transaction:
+$151.74M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Jazz Pharmaceuticals plcSHS USD(JAZZ)1,100,0001,500,000+400,000$132.46M$160.09M11.94%+$27.63M
Cytokinetics, Incorporated(CYTK)2,150,0002,075,000-75,000$150.74M$112.42M8.38%-$38.31M
Ascendis Pharma A/SADR(ASND)525,000750,000+225,000$79.36M$102.28M7.63%+$22.92M
Ultragenyx Pharmaceutical Inc.(RARE)110,0001,800,000+1,690,000$5.14M$73.98M5.52%+$68.84M
Globus Medical, Inc.CL A(GMED)1,000,000900,000-100,000$53.64M$61.64M4.60%+$8.00M
Insmed Incorporated(INSM)750,000750,0000$20.35M$50.25M3.75%+$29.90M
BeOne Medicines AGADR(ONC)325,000350,000+25,000$50.83M$49.93M3.72%-$892.3K
Soleno Therapeutics Inc1,250,0001,200,000-50,000$53.50M$48.96M3.65%-$4.54M
Endeavour Silver Corp.(EXK)100,000925,000+825,000$6.91M$39.08M2.91%+$32.18M
Arcellx Inc
COMMON STOCK
100,000675,000+575,000$6.96M$37.25M2.78%+$30.30M
Immatics N.V.SHS(IMTX)1,200,0002,750,000+1,550,000$12.61M$31.95M2.38%+$19.34M
Janux Therapeutics, Inc.(JANX)0725,000+725,000$0$30.37M2.26%+$30.37M
Astria Therapeutics Inc1,100,0003,250,000+2,150,000$15.48M$29.57M2.21%+$14.09M
KalVista Pharmaceuticals Inc655,0002,300,000+1,645,000$7.77M$27.09M2.02%+$19.33M
Savara Inc.(SVRA)06,490,000+6,490,000$0$26.15M1.95%+$26.15M
iTeos Therapeutics Inc01,750,000+1,750,000$0$25.97M1.94%+$25.97M
Applied Therapeutics Inc5,110,0005,430,000+320,000$34.75M$25.36M1.89%-$9.39M
Axsome Therapeutics, Inc.(AXSM)0300,000+300,000$0$24.15M1.80%+$24.15M
Structure Therapeutics IncADS0560,000+560,000$0$21.99M1.64%+$21.99M
Liquidia Corporation(LQDA)2,000,0001,830,000-170,000$29.50M$21.96M1.64%-$7.54M
ALX Oncology Holdings Inc.(ALXO)2,610,0003,600,000+990,000$29.10M$21.71M1.62%-$7.39M
uniQure N.V.SHS(QURE)4,725,0004,750,000+25,000$24.57M$21.28M1.59%-$3.29M
Bristol-Myers Squibb Company(BMY)0500,000+500,000$0$20.77M1.55%+$20.77M
Xenon Pharmaceuticals Inc.(XENE)400,000525,000+125,000$17.22M$20.47M1.53%+$3.25M
Praxis Precision Medicines, Inc.(PRAX)210,000440,000+230,000$12.81M$18.20M1.36%+$5.38M
Day One Biopharmaceuticals Inc
COM
01,250,000+1,250,000$0$17.23M1.28%+$17.23M
Inari Medical Inc800,000350,000-450,000$38.38M$16.85M1.26%-$21.53M
Dianthus Therapeutics, Inc.(DNTH)455,000600,000+145,000$13.65M$15.53M1.16%+$1.88M
Solid Biosciences Inc1,035,0002,665,000+1,630,000$13.79M$15.11M1.13%+$1.32M
Lexeo Therapeutics, Inc.(LXEO)175,000840,000+665,000$2.74M$13.47M1.00%+$10.73M
Apellis Pharmaceuticals Inc
COM
225,000335,000+110,000$13.23M$12.85M0.96%-$374.9K
Immunome, Inc.(IMNM)01,000,000+1,000,000$0$12.10M0.90%+$12.10M
Denali Therapeutics Inc.(DNLI)0500,000+500,000$0$11.61M0.87%+$11.61M
Nurix Therapeutics, Inc.(NRIX)0500,000+500,000$0$10.44M0.78%+$10.44M
Black Diamond Therapeutics Inc02,100,000+2,100,000$0$9.79M0.73%+$9.79M
BioNTech SEADS(BNTX)0100,000+100,000$0$8.04M0.60%+$8.04M
Inspire Medical Systems, Inc.(INSP)060,000+60,000$0$8.03M0.60%+$8.03M
Pacira BioSciences, Inc.(PCRX)80,000280,000+200,000$2.34M$8.01M0.60%+$5.67M
Dyne Therapeutics, Inc.(DYN)0225,000+225,000$0$7.94M0.59%+$7.94M
Fulcrum Therapeutics, Inc.(FULC)695,0001,160,000+465,000$6.56M$7.19M0.54%+$631.2K
Alto Neuroscience, Inc.(ANRO)250,000620,000+370,000$3.84M$6.63M0.49%+$2.79M
Fate Therapeutics, Inc.(FATE)800,0002,000,000+1,200,000$5.87M$6.56M0.49%+$688.0K
Allogene Therapeutics Inc1,350,0002,200,000+850,000$6.03M$5.13M0.38%-$908.5K
Passage Bio, Inc.(PASG)4,500,0006,052,000+1,552,000$6.08M$4.81M0.36%-$1.27M
Voyager Therapeutics, Inc.(VYGR)600,000600,0000$5.59M$4.75M0.35%-$840.0K
Lakefront Biotherapeutics NVADR(LKFT)130,000180,000+50,000$4.19M$4.46M0.33%+$274.4K
Zymeworks Inc.(ZYME)0440,000+440,000$0$3.74M0.28%+$3.74M
Relmada Therapeutics, Inc.(RLMD)1,200,0001,200,0000$5.58M$3.60M0.27%-$1.98M
MacroGenics, Inc.(MGNX)725,000800,000+75,000$10.67M$3.40M0.25%-$7.27M
Monte Rosa Therapeutics, Inc.(GLUE)0890,000+890,000$0$3.33M0.25%+$3.33M
Ventyx Biosciences Inc01,315,000+1,315,000$0$3.04M0.23%+$3.04M
PTC Therapeutics, Inc.(PTCT)090,000+90,000$0$2.75M0.21%+$2.75M
Verve Therapeutics Inc0500,000+500,000$0$2.44M0.18%+$2.44M
Iovance Biotherapeutics, Inc.(IOVA)0300,000+300,000$0$2.41M0.18%+$2.41M
Prime Medicine, Inc.(PRME)360,000450,000+90,000$2.52M$2.31M0.17%-$207.0K
Chimerix Inc1,400,0001,400,0000$1.48M$1.23M0.09%-$257.6K
Achilles Therapeutics PLCADS1,500,0001,500,0000$1.88M$1.22M0.09%-$652.5K
Atara Biotherapeutics Inc0112,000+112,000$0$952.0K0.07%+$952.0K
Reneo Pharmaceuticals Inc295,375545,000+249,625$490.3K$823.0K0.06%+$332.6K
Newamsterdam Pharma Co NV
ORDINARY SHARES
025,000+25,000$0$480.3K0.04%+$480.3K
Affimed NV55,0000-55,000$291.5K$0—-$291.5K
Agios Pharmaceuticals, Inc.(AGIO)325,0000-325,000$9.50M$0—-$9.50M
Alnylam Pharmaceuticals, Inc.(ALNY)350,0000-350,000$52.31M$0—-$52.31M
Alpine Immune Sciences Inc350,0000-350,000$13.87M$0—-$13.87M
argenx SEADR(ARGX)50,0000-50,000$19.69M$0—-$19.69M
AstraZeneca PLCADR(AZN)400,0000-400,000$27.10M$0—-$27.10M
Atara Biotherapeutics Inc2,800,0000-2,800,000$1.94M$0—-$1.94M
BioMarin Pharmaceutical Inc.(BMRN)175,0000-175,000$15.28M$0—-$15.28M
Bio-Rad Laboratories IncCL A15,0000-15,000$5.19M$0—-$5.19M
Geron Corporation(GERN)2,200,0000-2,200,000$7.26M$0—-$7.26M
Incyte Corporation(INCY)200,0000-200,000$11.39M$0—-$11.39M
Krystal Biotech, Inc.(KRYS)45,0000-45,000$8.01M$0—-$8.01M
Lyell Immunopharma, Inc.(LYEL)130,0000-130,000$289.9K$0—-$289.9K
Lyra Therapeutics Inc800,0000-800,000$4.98M$0—-$4.98M
Neurocrine Biosciences, Inc.(NBIX)710,0000-710,000$97.92M$0—-$97.92M
Novavax, Inc.(NVAX)500,0000-500,000$2.39M$0—-$2.39M
Sarepta Therapeutics, Inc.(SRPT)100,0000-100,000$12.95M$0—-$12.95M
Shockwave Medical Inc25,0000-25,000$8.14M$0—-$8.14M
TG Therapeutics, Inc.(TGTX)1,050,0000-1,050,000$15.97M$0—-$15.97M
Viking Therapeutics, Inc.(VKTX)75,0000-75,000$6.15M$0—-$6.15M
Page 1 of 1
Vestal Point Capital, LP — 13F Holdings — Q2 2024 | TickerTrail